Peters & Peters

Articles

In-depth commentary and expert insights

CAT rules in favour of NHS in significant competition claim against pharmaceuticals

Assange v USA — where are we now?

FCA steps up its ESG focus with introduction of anti-greenwashing rule

Mike Lynch acquittal turns spotlight on UK-US extradition deal

FCA doubles down on new priorities with target ID Plan

Tackling ESG regulation across multiple jurisdictions – a conundrum for multinationals